|
Bizportal I (14.06.10)
Clal Finance reviews 5 biomed companies |
|
|
Globes I (11.06.10)
4 stocks with potential |
|
|
Globes II (18.03.10)
Intec Pharma announced the successful completion of phase I clinical studies with its Accordion-Pill Baclofen
(AP-Baclofen) |
|
|
Bizportal II (16.02.10)
Intec Pharma investors smile after IPO |
|
|
Calcalist (14.02.10)
IPO success for Intec Pharma |
|
|
Globes III (11.02.10)
Success in the Initial Public Offering of Intec Pharma |
|
|
TheMarker (14.02.10)
Intec Pharma completed a 35 million NIS IPO in the Tel Aviv stock exchange |
